[ Price : $8.95]
FDA announces several actions aimed at accelerating the development of treatments for serious mental illness, following a recent e...[ Price : $8.95]
A recent FDA Warning Letter signals a broader regulatory focus on how drugmakers use artificial intelligence, according to a new a...[ Price : $8.95]
FDA issues AbbVie a complete response letter for its BLA for trenibotulinumtoxinE, an investigational, fast-acting botulinum toxin...[ Price : $8.95]
FDA sends an untitled letter to Incyte Corp., warning that portions of the companys consumer-facing Web site for Niktimvo (axatili...[ Price : $8.95]
CDER's Office of Compliance releases a new annual report showing that it expanded enforcement and oversight activities in 2025.[ Price : $8.95]
FDA raises multiple manufacturing and quality control concerns at a Swiss drug substance facility operated by Lonza Group, followi...[ Price : $8.95]
FDA releases a form FDA-483 with six observations from an inspection at Indias Global Calcium active pharmaceutical ingredient man...[ Price : $8.95]
Consumers for Dental Choice and two other advocacy groups again petition FDA to ban the use of mercury amalgams in dentistry, espe...